1[1]Tiulenev V I, Konoplich L A, Gurin S N, et al. Effect of adenosine triphosphate on the cleavage of H1 histones in nulei of rat spleen and liver[J]. Ukr Biokhim Zh,1996,68(6):23-29.
2[2]Drier J K, Swanson P E, Cherwitz D L, et al. S-100 protein immunoreactivity in poorly differentiated carcinomas. Immunohistochemical comparison with malignant melanoma[J]. Arch Pathol Lab Med,1987:111(5):447-452.
3[3]Gibbs F E, Wilkinson M C, Rudland P S, et al. Interactions in vitro of p9Ka, the rat S-100-related, metastasis-inducing[J]. J Biol Chem,1994 ,269(29):18 992-18 999.
4[4]Fano G, Biocca S, Fulle S, et al. The S-100: a protein family in search of a function[J]. Prog Neurobiol,1995, 46(1):71-82.
5[5]Buttner T, Wegers S, Postert T, et al. S-100 protein : serum marker of focal brain damage after isochemic territorical MCA infarction[J]. Stroke, 1997, 28(10): 1 961-1 965.
6[6]Yamazaki Y, Yada K, Morii S, et al. Diagnostic significance of serum neuron-specific enolase and myelin basic protein assay in patients with acute head injury[J]. J Surg Neurol,1995, 43: 267-271.
7[7]Eng L F. Progress in Neuropathology. VI 5. Raven Press. New york, London, 1980. 285.
8[8]Missler U, Wiesmann M. Measurement of S-100 protein in human blood and cerebrospinal fluid : analytical method and preliminary clinical results[J]. J Clin Chem Biochem,1995,33: 743-748.
9[9]Raichle M E. The pathophysiology of brain ischemia[J]. Ann Neurol,1983,13:2-10.
10[10]Persson L, Hardemark H G, Gustafsson J, et al. S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum:markers of cell damage in human central nervous system[J]. Stroke, 1987, 18: 911-918.
